Page DB - Search Results

1

Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival.

Ku GY, Yuan J, Page DB, Schroeder SE, Panageas KS, Carvajal RD, Chapman PB, Schwartz GK, Allison JP, Wolchok JD. Ku GY, et al. Among authors: page db. Cancer. 2010 Apr 1;116(7):1767-75. doi: 10.1002/cncr.24951. Cancer. 2010. PMID: 20143434 Free PMC article.

2

Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy.

Yuan J, Page DB, Ku GY, Li Y, Mu Z, Ariyan C, Gallardo HF, Roman RA, Heine AI, Terzulli SL, Ritter E, Gnjatic S, Ritter G, Jungbluth AA, Allison JP, Old LJ, Wolchok JD. Yuan J, et al. Among authors: page db. Cancer Immun. 2010 Jan 7;10:1. Cancer Immun. 2010. PMID: 20052966 Free PMC article.

3

Targeting cytotoxic T-lymphocyte antigen 4 in immunotherapies for melanoma and other cancers.

Page DB, Yuan J, Wolchok JD. Page DB, et al. Immunotherapy. 2010 May;2(3):367-79. doi: 10.2217/imt.10.21. Immunotherapy. 2010. PMID: 20635901 Review.

4

CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases.

Yuan J, Ginsberg B, Page D, Li Y, Rasalan T, Gallardo HF, Xu Y, Adams S, Bhardwaj N, Busam K, Old LJ, Allison JP, Jungbluth A, Wolchok JD. Yuan J, et al. Cancer Immunol Immunother. 2011 Aug;60(8):1137-46. doi: 10.1007/s00262-011-1011-9. Epub 2011 Apr 5. Cancer Immunol Immunother. 2011. PMID: 21465316 Free PMC article. Review.

5

Checkpoint modulation in melanoma: an update on ipilimumab and future directions.

Page DB, Postow MA, Callahan MK, Wolchok JD. Page DB, et al. Curr Oncol Rep. 2013 Oct;15(5):500-8. doi: 10.1007/s11912-013-0337-1. Curr Oncol Rep. 2013. PMID: 23933888 Free PMC article. Review.

6

Immune modulation in cancer with antibodies.

Page DB, Postow MA, Callahan MK, Allison JP, Wolchok JD. Page DB, et al. Annu Rev Med. 2014;65:185-202. doi: 10.1146/annurev-med-092012-112807. Epub 2013 Oct 30. Annu Rev Med. 2014. PMID: 24188664 Review.

7

Pretreatment serum VEGF is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab.

Yuan J, Zhou J, Dong Z, Tandon S, Kuk D, Panageas KS, Wong P, Wu X, Naidoo J, Page DB, Wolchok JD, Hodi FS. Yuan J, et al. Among authors: page db. Cancer Immunol Res. 2014 Feb;2(2):127-32. doi: 10.1158/2326-6066.CIR-13-0163. Cancer Immunol Res. 2014. PMID: 24778276 Free PMC article. Clinical Trial.

8

Immune checkpoint blockade.

Naidoo J, Page DB, Wolchok JD. Naidoo J, et al. Among authors: page db. Hematol Oncol Clin North Am. 2014 Jun;28(3):585-600. doi: 10.1016/j.hoc.2014.02.002. Hematol Oncol Clin North Am. 2014. PMID: 24880949 Review.

9

Immune modulation for cancer therapy.

Naidoo J, Page DB, Wolchok JD. Naidoo J, et al. Among authors: page db. Br J Cancer. 2014 Dec 9;111(12):2214-9. doi: 10.1038/bjc.2014.348. Epub 2014 Sep 11. Br J Cancer. 2014. PMID: 25211661 Free PMC article. Review.

10

CTLA-4 antibodies: new directions, new combinations.

Funt SA, Page DB, Wolchok JD, Postow MA. Funt SA, et al. Among authors: page db. Oncology (Williston Park). 2014 Nov;28 Suppl 3:6-14. Oncology (Williston Park). 2014. PMID: 25387681 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page